2025 annual financial data

XORTX Therapeutics Inc. 2025 Operating margin

XORTX Therapeutics Inc. 2025 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -3,313,012 USD and net income was -2,656,304 USD.
Operating cash flow was -2,817,190 USD.

Get free XORTX Therapeutics Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-3,313,012 USD
Net income
-2,656,304 USD
Operating cash flow
-2,817,190 USD